The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells

Eduardo Alvarez-Rivera1, Madeline Rodríguez-Valentín2, Nawal M Boukli1

  • 1Biomedical Proteomics Facility, Department of Microbiology and Immunology, Universidad Central del Caribe School of Medicine, Bayamόn, PR 00960, USA.

Viruses
|March 30, 2023
PubMed

Insights

Polysaccharide peptide (PSP) from Coriolus versicolor inhibits HIV-1 entry by regulating cofilin-1 phosphorylation. This study reveals PSP

Area of Science:

  • Cell Biology
  • Virology
  • Immunology

Background:

  • Actin depolymerization factor (ADF) cofilin-1 is crucial for cytoskeleton dynamics and is manipulated by HIV-1.
  • The unfolded protein response (UPR) markers Inositol-Requiring Enzyme-1α (IRE1α) and protein kinase R (PKR) are linked to actin regulation.
  • Previous research showed polysaccharide peptide (PSP) from Coriolus versicolor has anti-HIV properties in THP1 cells.

Purpose of the Study:

  • To investigate the role of PKR and IRE1α in cofilin-1 phosphorylation and HIV-1 restriction by PSP in THP1 cells.
  • To elucidate the mechanism by which PSP inhibits viral infectivity.

Main Methods:

  • Quantitative proteomics to analyze cytoskeletal and UPR regulators.
  • Measurement of HIV-1 p24 antigen in cell supernatant to assess PSP's antiviral potential.
  • Immunoblotting and RT-qPCR for biomarker validation (PKR, IRE1α, cofilin-1).
  • Use of PKR/IRE1α inhibitors to confirm their role in viral entry and cofilin-1 phosphorylation.

Main Results:

  • PSP treatment prior to HIV-1 infection significantly reduced viral infectivity.
  • PKR and IRE1α were identified as key regulators of cofilin-1 phosphorylation.
  • PSP treatment modulated cofilin-1 phosphorylation, contributing to viral restriction.

Conclusions:

  • PSP exhibits anti-HIV-1 activity by influencing cofilin-1 phosphorylation through PKR and IRE1α pathways.
  • PKR and IRE1α are critical mediators of cofilin-1 phosphorylation and HIV-1 restriction.
  • PSP represents a potential therapeutic agent for HIV-1 infection by targeting host cell factors.